Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Issued (2016 - 2024)

Tandem Diabetes Care (TNDM) has disclosed Shares Issued for 12 consecutive years, with $2.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Shares Issued fell 12.04% year-over-year to $2.3 million, compared with a TTM value of -$6.7 million through Dec 2024, down 260.85%, and an annual FY2024 reading of -$6.7 million, down 260.85% over the prior year.
  • Shares Issued was $2.3 million for Q4 2024 at Tandem Diabetes Care, up from -$4.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $50.7 million in Q4 2021 and bottomed at -$16.2 million in Q3 2021.
  • Average Shares Issued over 5 years is $6.7 million, with a median of $2.5 million recorded in 2023.
  • The sharpest move saw Shares Issued skyrocketed 1192.3% in 2020, then tumbled 3481.25% in 2023.
  • Year by year, Shares Issued stood at $9.2 million in 2020, then surged by 452.26% to $50.7 million in 2021, then plummeted by 87.98% to $6.1 million in 2022, then plummeted by 57.1% to $2.6 million in 2023, then fell by 12.04% to $2.3 million in 2024.
  • Business Quant data shows Shares Issued for TNDM at $2.3 million in Q4 2024, -$4.5 million in Q3 2024, and -$3.0 million in Q2 2024.